AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
AntiCan↑, selectivity↑, Apoptosis↑, TumCCA↑, Bacteria↓, tumCV↓, selectivity↑, Apoptosis↑, TumCCA↑,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
*Bacteria↓, tumCV↓, selectivity↑, ROS↑, Apoptosis↑, TumCMig↓, AntiCan↑,
AntiCan↑, ChemoSen↑, Zeb1↓, TumMeta↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
AntiCan↑, Apoptosis↑, P53↑, BAX↑, Bcl-2↓, PHB↓, ANXA1↓, hnRNPA1↓,
| - |
vitro+vivo, |
NSCLC, |
A549 |
|
|
|
- |
in-vitro, |
Lung, |
H1299 |
|
|
|
AntiCan↑, TumVol↓, NOTCH3↓, tumCV↓, TumCCA↑, TumCMig↓, CSCs↓, TumCP↓, Apoptosis↑, TumCI↓, ROS↑, TumCG↓, selectivity↑, DNMT1↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vivo, |
Lung, |
NA |
|
|
|
AntiCan↑, Igs↓, lipid-P↓, ROS↑, Casp3↑, Casp9↑, ChemoSideEff↓, Dose∅,
AntiCan↑, eff↑,
| - |
vitro+vivo, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
BC, |
4T1 |
|
|
|
Apoptosis↑, necrosis↑, ROS↑, mtDam↑, Ca+2↑, MPT↑, MMP↓, AntiCan↑, *AntiBio↑, *Inflam↓, *antiOx↓, *neuroP↑, p‑Akt↓, DHODH↓, Diff↑, MAPK↑,
AntiCan↑, TumVol↓, PI3K↓, IL6↓, p‑STAT3↓, chemoPv↑,
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
*antiOx↑, *AntiBio↑, *AntiDiabetic↑, *AntiCan↑, Dose↝, TumCP↓, ER Stress↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Casp12↝, NF-kB↓, P53↑,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Lung, |
PC9 |
|
|
|
AntiCan↑, TumCMig↓, GSH↓, Casp3↑, Apoptosis↑, ROS↑, HDAC1↓, Ac-histone H3↑, PUMA↑, BAX↑, PCNA↓, Bcl-2↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HT29 |
|
|
|
AntiCan↑, NRF2↓, Prx↓, ChemoSen↑, *Prx↑, *NRF2↑,
Showing Research Papers: 1 to 12 of 12
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 12
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
DHODH↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 1, lipid-P↓, 1, NRF2↓, 1, Prx↓, 1, ROS↑, 5,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1, MPT↑, 1, mtDam↑, 1, PHB↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Ac-histone H3↑, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Apoptosis↑, 8, BAX↑, 3, Bcl-2↓, 3, Casp12↝, 1, Casp3↑, 3, Casp9↑, 2, MAPK↑, 1, necrosis↑, 1, PUMA↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 3,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNMT1↓, 1, P53↑, 2, PCNA↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, Diff↑, 1, HDAC1↓, 1, NOTCH3↓, 1, PI3K↓, 1, p‑STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 1, hnRNPA1↓, 1, TumCI↓, 1, TumCMig↓, 3, TumCP↓, 2, TumMeta↓, 1, Zeb1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
ANXA1↓, 1, Igs↓, 1, IL6↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 2, Dose↝, 1, Dose∅, 1, eff↑, 1, selectivity↑, 4,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 11, chemoPv↑, 1, ChemoSideEff↓, 1, TumVol↓, 2,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 56
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 2,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1, antiOx↑, 1, NRF2↑, 1, Prx↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiDiabetic↑, 1, neuroP↑, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 10
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page